Moreover, the crucial role of STAT3 blockage in mediating HME’s anti-bladder cancer action was confirmed by the abrogation of HME-elicited cytotoxicity when HME failed to mitigate STAT3 activation (Figure 3C,D). Here, STAT3 is linked to urinary bladder cancer.